损伤控制复苏的演变改善创伤性剖腹术患者的死亡率:对1030例连续创伤性剖腹术的分析
该研究分析了1030例连续创伤性剖腹术患者,按损伤控制复苏实施进程分为三个阶段:前DCR期(2006-2007年)、过渡期(2008-2009年)和后DCR期(2010-2013年)。结果显示,后DCR期与前DCR期和过渡期相比,晶体液用量显著减少(p=0.001),血制品复苏相应增加(p=0.04)。晶体液复苏容量在前DCR期(OR 1.071,95%CI 1.03-1.1,p=0.01)和过渡期(OR 1.05,95%CI 1.01-1.14,p=0.01)是死亡率的独立预测因素,但在后DCR期与死亡率无关(OR 1.01,95%CI 0.96-1.09,p=0.1)。凝血病(p=0.01)和酸中毒(p=0.02)在所有三个阶段均与死亡率独立相关。作者认为,DCR的实施与创伤性剖腹术患者预后改善相关,损伤控制剖腹术的使用减少,晶体液使用减少而血制品使用增加。
要点
- 后DCR期与前DCR期和过渡期相比,晶体液用量显著减少(p=0.001),血制品复苏相应增加(p=0.04)。
- 晶体液复苏容量是前DCR期死亡率的独立预测因素(OR 1.071,95%CI 1.03-1.1,p=0.01),也是过渡期的独立预测因素(OR 1.05,95%CI 1.01-1.14,p=0.01),但在后DCR期与死亡率无关(OR 1.01,95%CI 0.96-1.09,p=0.1)。
- 凝血病(p=0.01)和酸中毒(p=0.02)在所有三个阶段均与死亡率独立相关。
- 患者人口学特征和损伤严重度评分在三个阶段保持不变。
- DCR实施后,损伤控制剖腹术的使用减少,晶体液使用减少而血制品使用增加。
适用人群与场景
- 接受创伤性剖腹术的患者,共1030例连续病例,分为前DCR期(2006-2007年)、过渡期(2008-2009年)和后DCR期(2010-2013年)三个阶段。
研究设计与关键结果
- 研究类型为预后研究,证据等级为III级;分析了1030例连续创伤性剖腹术患者,按DCR实施进程分为前DCR期(2006-2007年)、过渡期(2008-2009年)和后DCR期(2010-2013年)三个阶段。
- 患者人口学特征和损伤严重度评分在三个阶段保持不变。
- 后DCR期与前DCR期和过渡期相比,晶体液用量显著减少(p=0.001),血制品复苏相应增加(p=0.04)。
- 晶体液复苏容量是前DCR期死亡率的独立预测因素(OR 1.071,95%CI 1.03-1.1,p=0.01),也是过渡期的独立预测因素(OR 1.05,95%CI 1.01-1.14,p=0.01),但在后DCR期与死亡率无关(OR 1.01,95%CI 0.96-1.09,p=0.1)。
- 凝血病(p=0.01)和酸中毒(p=0.02)在所有三个阶段均与死亡率独立相关。
证据类型、等级与局限
- 证据类型为预后研究,证据等级为III级。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,DCR的实施与创伤性剖腹术患者预后改善相关,表现为损伤控制剖腹术使用减少、晶体液使用减少和血制品使用增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The aim of this study was to evaluate the related change in outcomes (mortality, complications) in patients undergoing trauma laparotomy (TL) with the implementation of damage control resuscitation (DCR). We hypothesized that the implementation of DCR in patients undergoing TL is associated with better outcomes.
METHODS: We analyzed 1,030 consecutive patients with TL. Patients were stratified into three phases: pre-DCR (2006-2007), transient (2008-2009), and post-DCR (2010-2013). Resuscitation fluids (crystalloids and blood products), injury severity score (ISS), vital signs, and laboratory (hemoglobin, international normalized ratio, lactate) parameters were recorded. Regression analysis was performed after adjusting for age, ISS, laboratory and vital parameters, comorbidities, and resuscitation fluids to identify independent predictors for outcomes in each phase.
RESULTS: Patient demographics and ISS remained the same throughout the three phases. There was a significant reduction in the volume of crystalloid (p = 0.001) and a concomitant increase in the blood product resuscitation (p = 0.04) in the post-DCR phase compared to the pre-DCR and transient DCR phases. Volume of crystalloid resuscitation was an independent predictor of mortality in the pre-DCR (OR [95% CI]: 1.071 [1.03-1.1], p = 0.01) and transient (OR [95% CI]: 1.05 [1.01-1.14], p = 0.01) phases; however, it was not associated with mortality in the post-DCR phase (OR [95% CI]:1.01 [0.96-1.09], p = 0.1). Coagulopathy (p = 0.01) and acidosis (p = 0.02) were independently associated with mortality in all three phases.
CONCLUSION: The implementation of DCR was associated with improved outcome in patients undergoing TL. There was a decrease in the use of damage control laparotomy, with a decrease in the use of crystalloid and an increase in the use of blood products.
LEVEL OF EVIDENCE: Prognostic study, level III.
参考来源
- Joseph B, Azim A, Zangbar B, et al. Improving mortality in trauma laparotomy through the evolution of damage control resuscitation: Analysis of 1,030 consecutive trauma laparotomies. J Trauma Acute Care Surg. 2017. PMID: 27805990. doi:10.1097/TA.0000000000001273
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。